BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28059612)

  • 1. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.
    Laffin M; Millan B; Madsen KL
    Gut Microbes; 2017 May; 8(3):221-224. PubMed ID: 28059612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
    Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
    Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation: past, present and future perspectives.
    Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
    Kump P; Högenauer C
    Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation beyond Clostridioides difficile infections.
    Wortelboer K; Nieuwdorp M; Herrema H
    EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
    Weingarden AR; Vaughn BP
    Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation in children: a brief review.
    Hourigan SK; Oliva-Hemker M
    Pediatr Res; 2016 Jul; 80(1):2-6. PubMed ID: 26982451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbial transplantation: an update.
    Bouri S; Hart A
    Curr Opin Clin Nutr Metab Care; 2018 Sep; 21(5):405-410. PubMed ID: 29939968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
    Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
    Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota transplantation: concept, methodology and strategy for its modernization.
    Zhang F; Cui B; He X; Nie Y; Wu K; Fan D;
    Protein Cell; 2018 May; 9(5):462-473. PubMed ID: 29691757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Leung V; Vincent C; Edens TJ; Miller M; Manges AR
    Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Allegretti J; Eysenbach LM; El-Nachef N; Fischer M; Kelly C; Kassam Z
    Inflamm Bowel Dis; 2017 Oct; 23(10):1710-1717. PubMed ID: 28858073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application and Potential of Fecal Microbiota Transplantation.
    Ooijevaar RE; Terveer EM; Verspaget HW; Kuijper EJ; Keller JJ
    Annu Rev Med; 2019 Jan; 70():335-351. PubMed ID: 30403550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.
    Millan B; Park H; Hotte N; Mathieu O; Burguiere P; Tompkins TA; Kao D; Madsen KL
    Clin Infect Dis; 2016 Jun; 62(12):1479-1486. PubMed ID: 27025836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.